Report Interpretation

Overview

JPMorgan’s Q4 2026 preview argues that Siemens should sustain positive underlying momentum through Q4 and into FY27. Its Overweight rating and €345 December 2027 target are unchanged, supported by demand in Smart Infrastructure and Mobility, an anticipated Digital Industries recovery, and portfolio simplification including the planned Healthineers spin-off.

Core views

Siemens is scheduled to report Q4 2026 results on 12 November. JPMorgan updated its model using company discussions, top-down data and peer read-across, and expects the year-to-date positive trend to persist. The report highlights continued Smart Infrastructure strength from data centers, utilities and related infrastructure; further evidence that Digital Industries is recovering; another strong Mobility order quarter; and only immaterial incremental cost inflation, which it believes Siemens has offset through pricing actions. These factors support a positive underlying outlook for Q4 and FY27, while the Healthineers spin-out becomes actionable ahead of a December spin-out report and a February AGM approval vote. At group level, JPMorgan forecasts Q4 industrial orders excluding Healthineers of €19.8bn, versus Bloomberg consensus of €17.8bn, with the 11% premium largely reflecting a Mobility forecast around 35% above consensus. It forecasts industrial revenue excluding Healthineers of €16.2bn versus €15.9bn consensus, and industrial profit excluding Healthineers of €2.8bn, around 5% ahead of consensus. In the full Q4 forecast, group orders are €27.8bn, 9% above consensus and 27% above Q4 2025; industrial profit is €3.808bn, 2% above consensus and 19% higher year on year. The forecast implies a 16.7% industrial-profit margin, 19 basis points above consensus and 136 basis points above the prior-year quarter. For Digital Industries, JPMorgan models orders of about €5.7bn, sales of €5.5bn and organic sales growth of roughly 8%, with a book-to-bill ratio above 1x. It expects software annual recurring revenue growth above 10%, within the normal range, which it believes should ease concerns about the software business. The division is forecast to deliver a 19.2% margin after approximately €45m of severance costs. The report sees this recovery as important because Digital Industries has faced margin pressure after demand normalized and customers and distributors destocked; it considers the chance of that weakness persisting to be low, but still identifies a delayed recovery as significant for the equity. Smart Infrastructure is expected to remain a principal earnings driver. JPMorgan forecasts €7.5bn of Q4 orders, €7.0bn of revenue, about 11% organic growth and a 20.2% margin, including about €22m of severance. The central demand mechanism is continuing data-center investment, alongside the broader infrastructure requirement associated with it. Mobility is forecast to generate €6.5bn of orders, €3.6bn of sales, around 11% organic growth and an 8.9% margin. The institution emphasizes that Mobility orders are inherently volatile because large contracts are lumpy, but sees the Q4 order backdrop as strong. The quarterly changes make only immaterial changes to FY26 and later estimates, generally within plus or minus 1% from orders through EPS. JPMorgan forecasts FY26 revenue of €83.0bn, adjusted EPS of €11.73 and free cash flow to the firm of €7.96bn; for FY27, it forecasts revenue of €89.9bn, adjusted EPS of €14.12 and FCFF of €11.22bn. FY27 revenue growth is forecast at 8.3%, adjusted EPS growth at 20.3%, and operating-profit margin at 16.1%. Relative to Bloomberg consensus, its FY27 EPS estimate is 10% higher, while FY27 industrial profit is 5% higher. JPMorgan also bases its constructive longer-term case on portfolio simplification. It argues that the eight-year effort has improved growth prospects, gross and operating margins, and free-cash-flow predictability. The Healthineers stake, stated as 67% with approximately €32bn fair value, is described as the next and potentially final step; Siemens plans to return roughly 30% of Healthineers to Siemens shareholders in 2027. The report views Siemens’ exposure to automation, software, electrification and mobility as capable of producing above-sector organic growth over multiple years. After structural change and investment, it expects management’s focus to shift toward execution, growth, margin expansion, returns and cash generation; it regards low leverage guidance as conservative during the CFO transition year. The €345 December 2027 target is unchanged and is set using a sum-of-the-parts framework, the market value of Siemens Energy, and JPMorgan’s MedTech team’s Healthineers fair-value assessment. JPMorgan applies a 10% holding-company discount and generally uses multiples below peer-group averages. Its SOTP table shows a base-case implied value of €354.1 per share, compared with a €284.2 current share price in the table, or 25% upside; the downside and blue-sky cases are €247.0 and €506.3 per share, respectively.

Analysis framework

JPMorgan combines company discussions, top-down indicators and peer read-across with divisional order, revenue and margin forecasts. It compares its estimates with Bloomberg consensus, makes limited forecast revisions, and values Siemens using reverse-DCF and sum-of-the-parts methods that separately assess operating divisions and investments.

Methodology notes

• Valuation methodsSOTP (Sum-of-the-Parts) Valuation

  Sum-of-the-parts valuation

  JPMorgan values Siemens’ divisions and investments separately, incorporates market value for Siemens Energy and its Healthineers fair-value view, then applies a 10% holding-company discount.

• Valuation methodsDCF (Discounted Cash Flow)

  Reverse-DCF valuation

  The report states that its reverse-DCF price-target methodology is unchanged; this framework assesses the assumptions embedded in valuation through future cash-flow expectations.

• Industry AnalysisVolume-price decomposition

  Orders, revenue and margin analysis by division

  The report evaluates quarterly performance through orders, organic sales growth, book-to-bill ratios and divisional margins across Digital Industries, Smart Infrastructure and Mobility.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Siemens (SIEGn.F, SIE GR)

  Primary covered company; expected to benefit from Smart Infrastructure demand, Digital Industries recovery, Mobility orders and portfolio simplification.

  Strengths

  Exposure to automation, software, electrification and mobility; resilient Smart Infrastructure demand; expected margin and cash improvement.

  Weaknesses

  Digital Industries has experienced margin pressure following normalized demand and destocking.

  Comparison

  JPMorgan’s FY27 EPS estimate of €14.12 is 10% above Bloomberg consensus of €12.84.

  Risks

  A protracted Healthineers exit, unfavorable M&A, a slow Digital Industries recovery, or weaker German macro and stimulus expectations could weigh on valuation.

Key data

• Q4 industrial orders ex-Healthineers€19.8bn11% above Bloomberg consensus of €17.8bn.
• Q4 industrial revenue ex-Healthineers€16.2bnVersus €15.9bn Bloomberg consensus.
• Q4 industrial profit ex-Healthineers€2.8bnApproximately 5% above Bloomberg consensus.
• Smart Infrastructure Q4 orders€7.5bnSupported by data-center and utility-related demand.
• Mobility Q4 orders€6.5bnStrong forecast, but potentially volatile because of large, lumpy contracts.
• FY27E adjusted EPS€14.1210% above Bloomberg consensus of €12.84.
• FY27E revenue€89.9bnForecast growth of 8.3% year on year.
• FY27E FCFF€11.22bnUp from €7.96bn forecast for FY26.

Impact & implications

JPMorgan sees continued Smart Infrastructure demand, a Digital Industries recovery and Mobility orders as supporting earnings and margin progression into FY27. It also views the proposed Healthineers distribution and the move from restructuring toward execution as important elements of the longer-term investment case.

Risks

• A protracted Healthineers exit would be negative for the shares, although JPMorgan considers the timetable investible ahead of the February AGM.
• Further acquisitions at high multiples, or disposals and partnerships, could hurt value in the short term.
• A slower-than-expected Digital Industries recovery would matter materially because it is Siemens’ flagship division.
• A material deterioration in perceptions of the German economy or stimulus plans could lower Siemens’ valuation multiple because of its correlation with the DAX.

What to watch

• Siemens’ Q4 2026 results on 12 November, particularly orders, Smart Infrastructure demand and Digital Industries margins.
• Digital Industries software ARR growth and evidence that destocking pressure has eased.
• Mobility order intake, given the volatility created by large contracts.
• The December Healthineers spin-out report and the February AGM approval process.
• Any M&A, disposal or partnership activity alongside shareholder-friendly actions.